Eevia Health Plc revises its Information Policy

Eevia Health Plc ("Eevia" or "The Company") has revised its Information Policy and changed the threshold for orders to 566 KSEK (50 KEUR).

Eevia has updated its Information Policy, according to Spotlight Stockmarket's requirements. One out of many updates is the policy related to informing the market about sales orders and contracts. While press releases earlier were made for sales orders over 10 KEUR, such press releases will now only be made for orders or contracts with a sales value over 50 KEUR.

A press release will also be made when the accumulated value of several smaller orders is over 50 KEUR. Anything beyond the ongoing day-to-day operations will always be informed.

"We were in 2022 criticized by some investors for offering too little information related to sales orders, so we lowered the threshold to KEUR 10. Lately, we have been criticized for informing about too small orders. After contemplating this, we have raised the threshold to KEUR 50 for informing about sales orders," says Stein Ulve, Eevia's CEO.

For further information, please contact:

Stein Ulve, CEO, Eevia Health Plc                          

Email: [email protected]  or [email protected]                     

Telephone: +358 400 22 5967     


Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.

Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia's other raw materials, such as bilberry, lingonberry, Chaga mushroom, and pine bark, are wild-harvested sustainably.

Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at the Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA.

To learn more, please visit or follow Eevia Health on LinkedIn@EeviaHealth. 

Om Eevia Health

Eevia Health targets health problems with bioactive extracts from plant material. The human body has an incredible ability to restore good health. However, sometimes the body needs active support. Our mission is to support good health and well-being with plant extracts which have scientifically documented health benefits. Eevia Health manufactures and markets organic ingredients from abundant plant material in the Arctic. Our products are targeted against low-grade inflammation, problems in eye and brain health, and metabolic effects. We collaborate with scientists in Finland and abroad to scientifically substantiate the positive effects of ingredients and also to document the safety of use.



Kurs ()
Förändring ()
Marknad Spotlight stock market Kortnamn EEVIA ISIN-kod FI4000496658


Stein Ulve IR-kontakt [email protected]